(3R,5S)-5-(Hydroxymethyl)-1-methylpyrrolidin-3-ol hydrochloride

Catalog No. :
ACLZCQ374
CAS No. :
107746-24-7
Molecular Formula :
C6H14ClNO2
Molecular Weight :
167.64

IUPAC Name:(3R,5S)-5-(hydroxymethyl)-1-methylpyrrolidin-3-ol hydrochloride

(3R,5S)-5-(Hydroxymethyl)-1-methylpyrrolidin-3-ol hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g98%$82.00Login to see priceIn stockInquiry
10g98%$138.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(3R,5S)-5-(Hydroxymethyl)-1-methylpyrrolidin-3-ol hydrochloride
IUPAC Name(3R,5S)-5-(hydroxymethyl)-1-methylpyrrolidin-3-ol hydrochloride
MDL No.MFCD12545916
Molecular FormulaC6H14ClNO2
Molecular Weight167.64
SMILESCl.CN1C[C@H](O)C[C@H]1CO
InChI KeyANKBLDRZORUBIK-RIHPBJNCSA-N
SynonymC6H14ClNO2 | (2S,4R)-4-HYDROXY-1-METHYL-2-PYRROLIDINEMETHANOL HYDROCHLORIDE | (3R,5S)-5-(hydroxymethyl)-1-methylpyrrolidin-3-ol;hydrochloride | (3R,5S)-5-(Hydroxymethyl)-1-methylpyrrolidin-3-ol--hydrogen chloride (1/1) | AMY36419 | 2-Pyrrolidinemethanol,4
CAS No.107746-24-7
PubChem CID50998341

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACLZCQ374 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACLTOS597 route compound structure diagram
    ACLTOS597478922-47-3 In Stock
  4. Then
  5. ACLZCQ374 route product structure diagram
    ACLZCQ374107746-24-7 In Stock
Inquiry

2. ACLZCQ374 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACVQYS652 route compound structure diagram
    ACVQYS65213135-69-8 In Stock
  2. Then
  3. ACLZCQ374 route product structure diagram
    ACLZCQ374107746-24-7 In Stock
Inquiry

Comments (0)